LifeStance Health Group, Inc. (LFST) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. At $7.47, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: UnitedHealthcare (14.0%); Concentration risk — Customer: Elevance Health, Inc. (15.0%).
LifeStance Health operates one of the largest outpatient mental health platforms in the U.S., with 8,040 licensed clinicians in 33 states offering psychiatric, psychological, and therapy services in-person and virtually. Revenue is generated primarily through in-network... Read more
Sell if holding. At $7.47, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: UnitedHealthcare (14.0%); Concentration risk — Customer: Elevance Health, Inc. (15.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.3/10, moderate confidence.
Passes 5/7 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerUnitedHealthcare14%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue'
- HIGHCustomerElevance Health, Inc.15%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue'
Material Events(8-K, last 90d)
- 2026-03-11Item 5.02LOWLisa Miller promoted to Chief Operating Officer and Principal Operating Officer effective March 10, 2026. Previously EVP Practice Operations. No departure of prior COO cited.SEC filing →
- 2026-02-25Item 5.02LOWKenneth Burdick transitions from Executive Chairman to non-executive Chairman effective March 16, 2026. Will receive standard non-employee director compensation. Not due to disagreement.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $7.47, A.R:R 0.9:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: UnitedHealthcare (14.0%); Concentration risk — Customer: Elevance Health, Inc. (15.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $7.04. Score 5.3/10, moderate confidence.
Take-profit target: $8.55 (+14.1% upside). Prior stop was $7.04. Stop-loss: $7.04.
Concentration risk — Customer: UnitedHealthcare (14.0%); Concentration risk — Customer: Elevance Health, Inc. (15.0%); Earnings in 7 days (event risk).
LifeStance Health Group, Inc. trades at a P/E of 371.5 (forward 19.4). TrendMatrix value score: 6.3/10. Verdict: Sell.
17 analysts cover LFST with a consensus score of 4.1/5. Average price target: $10.
What does LifeStance Health Group, Inc. do?LifeStance Health operates one of the largest outpatient mental health platforms in the U.S., with 8,040 licensed...
LifeStance Health operates one of the largest outpatient mental health platforms in the U.S., with 8,040 licensed clinicians in 33 states offering psychiatric, psychological, and therapy services in-person and virtually. Revenue is generated primarily through in-network insurance reimbursements, with 95% of patients insured as of their latest visit in 2025. Two payors, UnitedHealthcare (14%) and Elevance Health (15%), each exceeded 10% of total revenue.